Your body runs on a constant cycle of damage and repair. Every time you breathe, digest food, or fight off an infection, your cells produce unstable molecules that can harm DNA, proteins, and cell membranes. NADPH (reduced nicotinamide adenine dinucleotide phosphate) is the molecule your cells depend on to clean up that damage. Without enough of it, repair falls behind, and the balance tips toward accumulated cellular wear.
This test measures NADPH concentration in your blood, reported in nmol/ml. Because NADPH is not yet part of routine clinical panels, most people have never seen this number. That makes it a genuinely novel data point: a window into the cellular chemistry that underpins aging, immune defense, and metabolic resilience, measured directly rather than inferred from downstream markers.
NADPH works as a rechargeable battery for your cells' protective systems. Its primary job is to recycle your most important internal antioxidant, a molecule called glutathione. When glutathione neutralizes a harmful unstable oxygen molecule (called a free radical), glutathione itself becomes "spent." NADPH is what recharges it so it can go back to work. Without NADPH, your glutathione system stalls.
Beyond antioxidant recycling, NADPH supplies the chemical energy cells need to build fats, cholesterol, and the building blocks of DNA. It also powers a dedicated immune weapon: an enzyme complex called NADPH oxidase that your white blood cells use to generate bursts of toxic oxygen to kill bacteria and fungi.
Your cells produce NADPH through several routes. The largest source in most cells is a glucose processing side-pathway (called the pentose phosphate pathway), where an enzyme called G6PD does the heavy lifting. A second major source involves folate (vitamin B9) metabolism. Fat cells rely on a different enzyme entirely (called malic enzyme). This redundancy means your body has backup systems, but those backups are not unlimited.
NADPH is unusual among biomarkers because both deficiency and excess can cause problems. Too little NADPH leaves your cells unable to neutralize oxidative damage, weakening antioxidant defenses and stalling the production of essential molecules. The most dramatic example is G6PD deficiency, the most common enzyme disorder worldwide, affecting over 400 million people. People with this condition cannot produce enough NADPH in their red blood cells, making them vulnerable to episodes where red blood cells break apart (hemolytic anemia) when exposed to certain medications, foods, or infections.
On the other side, tumor cells often ramp up NADPH production to fuel rapid growth and shield themselves from the oxidative stress that might otherwise slow them down. Excess NADPH can also create a chemical imbalance called reductive stress, which is itself damaging, particularly in the cardiovascular system. The relationship between NADPH and disease has been linked to conditions including Alzheimer's disease, Parkinson's disease, stroke, diabetes, and obesity, though whether NADPH is protective or harmful depends on the specific disease and the cellular compartment involved.
One of NADPH's most visible clinical roles is in immune function. Your immune cells use the NADPH oxidase enzyme to generate reactive oxygen as a weapon against invading microbes. When this system fails completely, as in chronic granulomatous disease (CGD), people suffer recurrent, severe bacterial and fungal infections. CGD is rare (about 1 in 200,000 to 250,000 births), but severe G6PD deficiency can mimic it, because the immune cells cannot produce enough NADPH to fuel the oxidase.
What makes this even more counterintuitive: phagocytes (the immune cells that engulf pathogens) from people with CGD actually show elevated oxidative stress, not less. Their cells' energy-producing compartments (mitochondria) generate excess reactive oxygen, creating a cellular imbalance. This finding challenges the simple assumption that immune cells in these patients just lack oxidative capacity.
Animal studies suggest that maintaining higher NADPH levels may protect against aging. In one study, mice genetically engineered to produce moderately more G6PD (the rate-limiting enzyme for NADPH production) had higher NADPH levels, less oxidative damage, and longer median lifespans in females. A separate study found that boosting NADPH production in the cells lining blood vessels slowed vascular aging in mice.
In humans, a study of 30 individuals (15 young, average age 29; 15 elderly, average age 81) found that the oxidized form (NADP+) decreased significantly with age. A separate plasma metabolomics study spanning ages 20 to 87 found a similar decline in NADP+ but also reported that NADPH (the reduced form) actually increased with age, along with an increase in the NADPH/NADP+ ratio, suggesting the body may shift its balance between the two forms as a compensatory response. These findings are preliminary, and the direction of change may vary by tissue, but they hint that your NADPH system does not stay static as you age.
For cardiovascular health, the picture is complex. Both insufficient and excess NADPH can contribute to blood vessel damage. NADPH feeds the antioxidant systems that protect vessel walls, but it also fuels NADPH oxidase in those same vessels, which, when overactive, generates the very reactive oxygen species that promote atherosclerosis. This duality means the ratio of NADPH to its oxidized form (the NADPH/NADP+ ratio) may matter more than the absolute level of either molecule alone.
NADPH measurement is technically challenging, which is one reason it has not become a standard clinical test. The molecule is fragile: it can convert to its oxidized form (NADP+) during sample handling, so blood samples require careful extraction procedures to get an accurate reading. Several lab methods exist, including HPLC with fluorescence detection (linear range 0.1 to 5.0 micromolar, a unit for very small blood concentrations), mass spectrometry, and spectrophotometric assays. Different methods can give different numbers for the same sample, which is why comparing results from the same lab over time matters more than matching a universal reference range.
NADPH does not have established clinical reference ranges endorsed by any major medical society. This is a Tier 3 (research/exploratory) biomarker. The values below come from research settings and should be treated as orientation, not diagnostic thresholds. Your result's meaning comes primarily from tracking your own trend over time, not from comparing against a single cutpoint.
| Measurement Context | Reported Range | What It Suggests |
|---|---|---|
| HPLC detection range (red blood cells) | 0.1 to 5.0 micromolar | Analytical range for research assays; not a clinical normal range |
| Electrochemical detection range | 10.0 micromolar to 1.50 millimolar | Broader detection range used in some enzyme activity assays |
| NADPH/NADP+ ratio | No consensus value established | The ratio may be more informative than either absolute level; a higher ratio generally reflects stronger cellular reducing capacity |
These are analytical detection ranges from research studies, not clinical interpretation tiers. Your lab may report in nmol/ml. Because assay methods vary, do not compare a result from one lab to a threshold published by another. Instead, use the same lab each time and watch your trend.
NADPH is a dynamically regulated molecule. Research using real-time biosensors inside living cells shows that NADPH levels can shift within minutes in response to changes in glucose availability, oxidative stress, or metabolic demand. Cells actively maintain NADPH balance through rapid compensatory mechanisms, meaning a single blood draw captures only a snapshot of a constantly moving target.
A meta-analysis of NADPH measurements across mammalian tissues found significant variability both within and between measurement methods, with relatively poor reproducibility across different experiments. One research study reported a within-run precision (coefficient of variation) of 8.6% for NADPH in red blood cells. This means even under ideal lab conditions, repeated measurements of the same sample can differ by roughly 9%.
For all these reasons, a single NADPH result tells you far less than a series of results over time. Get a baseline, retest in 3 to 6 months if you are making lifestyle or supplement changes, and then at least every 6 to 12 months to establish your personal trend. Because this is a newer measurement without standardized cutpoints, building your own longitudinal data is especially valuable. You will have your own history to compare against as the science matures.
Several factors can distort a single NADPH reading and lead you to the wrong conclusion.
To minimize these artifacts, draw your blood at a consistent time of day, in a non-fasting or consistently fasting state, when you are not acutely ill, and at least 48 hours after intense exercise.
Evidence-backed interventions that affect your NADPH level
NADPH is best interpreted alongside these tests.